| Oct. 4, 2004 | |||||||||
In Print![]() Photo by Leah Gourley
From Focus: Chemical genetics, the use of small inhibitors to disrupt biological pathways, may uncover interactions that traditional genetics misses. In the Oct. 1 Science, Randall King and colleagues describe a chemical genetic screen that uncovered ubistatins, small chemicals that interfere in a totally unexpected way with the cell's protein recycling system. Ubistatins, which bind to the interface between two ubiquitin molecules, make ubiquitin tags unrecognizable to the protein-recycling proteasome, thereby inhibiting protein degradation. Targeting the ubiquitin-ubiquitin interface could prove a novel approach to treating cancer.
|
|
HeadlinesStudy Says Therapy Better than Pills in Treating Sleep-onset Insomnia [Select "In Research"] Study Finds that Blacks are Significantly Less Likely to Undergo Prostate Cancer Screening Rare Childhood Genetic Syndrome Identified Researchers Clarify Mechanisms for Beta-Cell Formation in Response to Insulin Resistance
UpcomingHuman Disease Seminar Series:"The Challenges of Tropical Diseases" Alex Matter, Director, Novartis Institute for Tropical Diseases Oct. 13 3:45 p.m.
|
Spotlight
Student Scene
Lab WorksA multimedia site featuring Harvard Medical research. |
||||||
Calendar | Jobs | Harvard Medical School Home | Hospitals | Back Issues | Feedback | Home |